News
News
NGMedical will present its unique product portfolio at EUROSPINE
New partnership with NEUROWAVE for MOVE®-C disc prosthesis distribution in Portugal
Australian TGA approval for MOVE®-C cervical artificial disc prosthesis
Completion of Patient Enrollment in the one- and two-Level MOVE®-C Clinical Trial
NGMedical presents its MOVE® -C cervical artificial disc prosthesis at NASS and EUROSPINE
New revenue record with MOVE®-C cervical artificial disc prosthesis
One-year anniversary of the new headquarter in Germany
First implantation of the MOVE®-C cervical artificial disc prosthesis in Mexico
Sales launch and first implantation of MOVE®-C artificial cervical disc in the United Arab Emirates
Approval for MOVE® -C cervical artificial disc prosthesis in Mexico
First implantation of the MOVE®-C cervical artificial disc prosthesis in Taiwan
1,000 implantations of the MOVE®-C cervical artificial disc prosthesis
FDA Clearance for BEE
Publication MOVE-C “zur Gesundheit”
Launch of BEE 3D Ti Cervical Interbody Cage
First Implantations with MOVE-C Cervical Disc Prostheses
